Campus to Host Jan. 17 Tribute to Martin Luther King, Jr.
Campus will host a tribute to Martin Luther King, Jr., at noon, Wednesday, Jan. 17, in the Great Hall, Tangeman University Center.
The event is sponsored by the African American Cultural & Resource Center and is titled Remnants of the Dream: Deferred, Devalued, Yet Deliverable.
The program consists of:
- 11:30 a.m.: Doors open
- 11:45 a.m.-12:05 p.m.: Ngoma and the Black Arts Collaborative
- Noon: Opening presentation: LeLAnd Brown, Carver Ealy and P. Eric Watford
- Opening Remarks: Ms. Kuamka and Mr. Mr. Kuamka 2018
- Official University Welcome: President Neville Pinto
- Additional welcome: Vice President for Student Affairs Debra Merchant
- Official Student Welcomes: Student Government Association, Presidents, United Black Student Association
- Universal Prayer: Leslie Keener, Catholic Campus Minister, University of Cincinnati,St. Monica-St. George Parish Newman Center
- Statement of Deliverables: Eric Abercrumbie, Executive Director, Student Affairs Special Initiatives & Community Relations
- Introduction of Speaker: Habari Gani Ambassador
- Musical selection: AACRC Choir
- Keynote Address: Rev. Damon Lynch, Pastor, New Prospect Baptist Church
- Special Presentation: Mr. & Miss Kuamka
- Closing Remarks: P. Eric Watford, MLK Chair
- "The Charge:"Carver Ealy
See more events celebrating and promoting equity, inclusion and engagement.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.